US Patent

US12083087 — Aqueous formulation comprising paracetamol and ibuprofen

Method of Use · Assigned to Hyloris Pharmaceuticals SA · Expires 2035-07-17 · 9y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects an aqueous formulation of paracetamol and ibuprofen with a pH of 6.3-7.3 for use as a medicament.

USPTO Abstract

An aqueous ibuprofen and paracetamol composition has a pH 6.3-7.3. The composition can be used as a medicament, especially for the treatment of pain and/or inflammation. The composition can be formulated for intravenous injection.

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3744`	—	chembl-chembl112

Patent Metadata

Patent number: US12083087
Jurisdiction: US
Classification: Method of Use
Expires: 2035-07-17
Drug substance claim: No
Drug product claim: No
Assignee: Hyloris Pharmaceuticals SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.